Results of surgical treatment of patients with multiple brain metastases


Cite item

Full Text

Abstract

Objective: to evaluate the results of surgical treatment ofpatients with multiple brain metastases and to determine prognostic factors. Material and methods. 57 patients with multiple brain metastases were operated, 146 metastatic foci were removed. All metastases were removed in 42 persons; only large clinically significant metastases were removed in 15 patients. Whole brain radiation therapy was applied in 37patients, alone or in combination with chemotherapy, 20 patients after surgery received only corticosteroid and symptomatic therapy. Results. Median survival time of the whole group was 7.3 months; for patients, who received adjuvant whole brain radiation therapy - 11.6 months. Two-year survival was 8.8 %. The number of patients with Karnofsky performance score ≥ 70 increased from 12 persons (21,1%) at admission to the hospital to 38 (66.7 %) at 9-1th day after surgery. Median survival time for patients with complete resection was 9,2 months, with partial resection - 3,7 months. Prognostic factors were Karnofsky performance score and RPA class, estimated before operation, but after the corticosteroid therapy: median survival time for patients with RPA-class I was 19.5 monthsversus 5.6 months for patients with RPA- class II and III. Conclusions. Surgery rapidly improves the condition of patients with multiple brain metastases and saves the time for postoperative adjuvant treatment. Median survival time for patients who received adjuvant whole brain radiation therapy reaches 11.6 months. Favorable prognostic factors for prolonged survival are total resection of all lesions, RPA-class I and adjuvant whole brain radiation therapy.

About the authors

Liudmila R. Kurilina

Volga District Medical Centre; Nizhny Novgorod State Medical Academy

Email: lkurilina@yandex.ru
MD, PhD, assistant professor of the Department of neurology, neurosurgery and medical genetics of the Nizhny Novgorod State Medical Academy Nizhny Novgorod, Russian Federation, 603001

A. F Rekhalov

Volga District Medical Centre

Nizhny Novgorod, Russian Federation, 603001

S. S Pavlov

Volga District Medical Centre

Nizhny Novgorod, Russian Federation, 603001

V. A Kolesnikov

Volga District Medical Centre

Nizhny Novgorod, Russian Federation, 603001

P. V Smirnov

Volga District Medical Centre

Nizhny Novgorod, Russian Federation, 603001

References

  1. Белов Д.М., Карахан В.Б., Вишневская Я.В., Алешин В.А. Особенности хирургии церебральных церебральных метастазов рака в зависимости от структурно-морфологических особенностей очага. Вестник неврологии, психиатрии и нейрохирургии. 2010; (9): 54-6.
  2. Craighead P.S., Chan A. Defining treatment for brain metastases patients: nihilism versus optimism. Support Care Cancer. 2012; 20: 279-85.
  3. Scharckert G., Lindner C., Petschke S., Leimert M., Kirsch M. Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome. Acta Neurochir. 2013; 155: 379-87.
  4. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363: 1665-72.
  5. Patil C.G., Pricola K., Sarmiento J.M., Garg S.K., Bryant A., Black K.L. Whole brain radiation Therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst. Rev. 2012; (9): CD006121.
  6. Paek S.H., Audu P.V., Sperling M.R., Cho J., Andrews D.W. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery. 2005; 56: 1021-34.
  7. Аусландс К.Я., Карклиня Ю.В., Апшкалне Д.Л., Озоле Р.Я. Влияние клинических факторов на продолжительность жизни в послеоперационном периоде у больных с множественными метастазами злокачественных опухолей в головной мозг. Нейрохирургия. 2013; (1): 31-9.
  8. Gaspar L., Scott C., Rotman M., Asbell S., Phillips T., Wasserman T. et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 1997; 37 (4): 745-51.
  9. Карахан В.Б. Современные принципы хирургии множественных метастазов злокачественных опухолей в головной мозг. В кн.: Материалы IV Международной конференции «Реабилитация в медицине». Ереван; 2009: 152-6.
  10. Kocher M., Soffietti R., Abacioglu U., Villa S., Fauchon F., Baumert B.G. et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J. Clin. Oncol. 2011; 29: 134-41.
  11. Bindal R.K., Sawaya R., Leavens M.E., Lee J.J. Surgical treatment of multiple brain metastases. J. Neurosurg. 1993; 79: 210-6.

Copyright (c) 2016 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies